Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 136 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1351 9.0 months Metastatic melanoma 4 Biologic therapy
Haukeland University Hospital Norway 6/2012
Treatment Details: Patients: This phase 2 study involved 35 metastatic melanoma patients with a median age of 63 years; 54% were male. Treatment: Patients were treated with the biologic therapy agent beva
 
1352 9.0 months Malignant glioma 4 Biologic therapy
The University of Texas MD Anderson Cancer Center United States 5/2011
Treatment Details: Patients: This phase II study involved 42 recurrent malignant glioblastoma patients. The median patient age was 55 years and 25 were male. Treatment: Patients were treated with the bio
 
1353 9.0 months GBM 4 Biologic therapy
Chemotherapy
Harvard Medical School United States 1/2015
Treatment Details: Patients: This phase 2 study involved patients who were divided into groups based on their cancer type. Group A consisted of 24 glioblastoma patients with median age of 53 years; 41.7% were
 
1354 9.0 months Advanced NSCLC 4 Chemotherapy
Versilia Hospital and Istituto Toscano Tumori Italy 5/2015
Treatment Details: Patients: This phase 2 study involved 43 elderly advanced non-small cell lung cancer patients who had not received prior chemotherapy. The median patient age was 80 years (range: 70-92) an
 
1355 8.9 months Recurrent GBM 4 Biologic therapy
Columbia University Medical Center United States 7/2015
Treatment Details: Patients: This phase 2 study involved 29 recurrent glioblastoma patients who had been previously treated with surgery, radiation, and temozolomide chemotherapy. The median patient age was
 
1356 8.9 months Advanced hepatocellular carcinoma 4 Chemotherapy
Taipei Veterans General Hospital Taiwan Region 10/2007
Treatment Details: Patients: This study involved 66 advanced hepatocellular carcinoma patients with a median age of 52 years; 86% were male. Treatment: Patients were treated with the chemotherapy agents e
 
1357 8.9 months Metastatic urothelial carcinoma 4 Chemotherapy
Sapporo Medical University Urologic Oncology Consortium Japan 6/2011
Treatment Details: Patients: This phase II study involved 45 previously-treated metastatic urothelial carcinoma patients with a median age of 68 years; 32 patients were male. Treatment: Patients in this s
 
1358 8.9 months Advanced breast cancer 4 Immunotherapy
Comprehensive Cancer Center of Wake Forest University United States 1/2004
Treatment Details: Patients: This Phase II study involved 38 patients with advanced breast cancer. Prior therapies included hormonal (21 patients), chemotherapy (37 patients), and radiotherapy (24 patients).
 
1359 8.9 months Advanced colorectal cancer 4 Biologic therapy
Chemotherapy
Odense University Hospital Denmark 2/2008
Treatment Details: Patients: This study involved 74 patients with advanced colorectal cancer. All had previously been treated with the chemotherapy drugs irinotecan, oxaliplatin, and/or fluorouracil. The me
 
1360 8.9 months Stage IV melanoma 4 Chemotherapy
Immunotherapy
Umea University Hospital Sweden 8/2007
Treatment Details: Patients: This phase III study involved 241 patients with stage IV melanoma. They were divided into two treatment groups. The median age of patients was 52 years in one group and 53 in th
 
Page 136 of 187  | Previous Page  | Next Page